Summary of Study ST001408
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000964. The data can be accessed directly via it's Project DOI: 10.21228/M83406 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST001408 |
| Study Title | Metabolomic profiling of baseline plasmas from a longitudinal prospective cohort of 491 active surveillance (AS) participants |
| Study Type | Biomarker study |
| Study Summary | Untargeted metabolomics analyses were performed on clinically matched baseline plasma samples (n = 16 per group) prospectively collected from patients with clinically low-risk early stage prostate cancer undergoing AS who exhibited early disease progression (DP) (defined as upgrading of Gleason score (GS) and/or increased tumor volume on surveillance biopsy within 18 months after start of AS) or indolent disease (no progression for five or more years after start of AS) as well as 459 baseline plasma samples prospectively collected from patients with early-stage prostate cancer undergoing AS. |
| Institute | University of Texas MD Anderson Cancer Center |
| Department | Department of Clinical Cancer Prevention |
| Last Name | Vykoukal |
| First Name | Jody |
| Address | 6767 Bertner Ave, Houston, TX 77030 |
| jvykouka@mdanderson.org | |
| Phone | 713-834-6095 |
| Submit Date | 2020-05-19 |
| Raw Data Available | Yes |
| Analysis Type Detail | LC-MS |
| Release Date | 2020-07-02 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR000964 |
| Project DOI: | doi: 10.21228/M83406 |
| Project Title: | AS Biomarker Project |
| Project Type: | Biomarker |
| Project Summary: | Metabolomic profiling of baseline plasmas from a longitudinal prospective cohort of 491 active surveillance (AS) participants with the objective of identifying metabolic fingerprints that predict Gleason grade progression. |
| Institute: | University of Texas MD Anderson Cancer Center |
| Department: | Department of Clinical Cancer Prevention |
| Last Name: | Vykoukal |
| First Name: | Jody |
| Address: | 1515 Holcombe Boulevard, Houston, Texas, 77030, USA |
| Email: | jody@mdanderson.org |
| Phone: | 8327243044 |
